Lyndra Raises $23 Million in Series A Financing to Advance Ultra-Long Acting Oral Therapeutic Delivery Read more
Ligand Enters Commercial License and Supply Agreements with Marinus Pharmaceuticals for Captisol-Enabled Ganaxolone Read more
Mallinckrodt Completes Sale Of Its Intrathecal Therapy Business To Piramal Enterprises Limited Read more